Skip to main content
. 2017 Apr 3;8(21):34858–34866. doi: 10.18632/oncotarget.16799

Table 4. Within-run and between-run precision performance for variant frequency calling.

Sample: variant Within-run Total
Replicates Mean, % SD, % CV, % Replicates Mean, % SD, % CV, %
YMC1: BRCA1, c.5496_5506delinsA 3 45.27 1.03 2.27 5 45.72 1.28 2.79
YMC2: BRCA2, c.2798_2799del 3 47.53 0.15 0.32 5 49.44 2.61 5.29
YMC3: BRCA1, c.922_924delinsT 3 49.53 1.01 2.04 5 50.40 2.08 4.13
YMC1: 8 heterozygote SNVs 3 49.89 1.56 3.12 5 49.64 1.86 3.76
YMC2: 7 heterozygote SNVs 3 49.36 1.69 3.42 5 49.69 1.92 3.86
YMC3: 14 heterozygote SNVs 3 50.09 1.50 3.00 5 50.06 1.79 3.57

YMC = Yonsei Medical Center; SD = standard deviation; CV = coefficient of variation.